Predictors of progression of multiple sclerosis in a sample of Egyptian patients

被引:1
作者
Shawky, Manar A. [1 ]
Menecie, Tarek I. [2 ]
El Deen, Eman M. Saif [3 ]
Rashad, Mohammed H. [2 ]
机构
[1] Nasser Inst Hosp Res & Treatment, Neurol Dept, Cairo, Egypt
[2] Al Azhar Univ, Fac Med Boys, Neurol Dept, Cairo, Egypt
[3] Al Azhar Univ, Al Azhar Univ Girls, Neurol Dept, Cairo, Egypt
关键词
Multiple sclerosis; Progression; Predictors; Expanded Disability Status Scale (EDSS); SECONDARY PROGRESSION; DISEASE PROGRESSION; OLIGOCLONAL BANDS; VITAMIN-D; DISABILITY; RISK; OUTCOMES; SMOKING;
D O I
10.1186/s41983-023-00779-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background Multiple sclerosis (MS) is a multifactorial neurodegenerative autoimmune disease with a varied clinical course and presentation, which is more frequent than ever in the Middle East. The aim of this work is to investigate potential predictors of MS progression in order to help in early diagnose and predict progressive course of the disease.Results This is a retrospective case-control study conducted on a group of multiple sclerosis (MS) patients who developed secondary progression of the disease course (SPMS). The cases were matched with control MS patients who did not develop any disease progression (relapsing remitting MS (RRMS)). The matching was done for sex, and age with a ratio 1:1, total of 150 patients were included as cases and were matched with 150 control patients. Significant associations between MS progression and smoking, vitamin D deficiency, disease duration, delay in MS diagnosis, unemployment, site and number of lesions, and number of black holes were reported. About half of SPMS patients (53.3%) had 3 or more spinal lesions compared to only 1.4% of RRMS patients (p < 0.001). Moreover, about 76% of RRMS patients had no black holes in their radiological finding, while it was found that 35.3% of the SPMS patients had more than 5 black holes, compared to 8% of RRMS patients. Additionally, juxta-cortical site lesions were more frequent in SPMS than that in RRMS in a percentage 72.7 and 46%, respectively. Also, infra-tentorial lesions were found to be more frequent in SPMS group rather than RRMS group 92% and 78.7%, respectively.On the other hand, a lower SDMT scale was associated with a shorter time to SPMS diagnosis in the multivariate Cox regression analysis adjusted to baseline factors and 25-FWT (HR: 0.928, 95% CI: 0.906-0.95).Conclusions MS secondary progression can be predicted among MS patients in routine practice comprising exposure history, clinical assessment, laboratory findings, and radiological examinations.
引用
收藏
页数:8
相关论文
共 35 条
[1]   Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression [J].
Ascherio, Alberto ;
Munger, Kassandra L. ;
White, Rick ;
Koechert, Karl ;
Simon, Kelly Claire ;
Polman, Chris H. ;
Freedman, Mark S. ;
Hartung, Hans-Peter ;
Miller, David H. ;
Montalban, Xavier ;
Edan, Gilles ;
Barkhof, Frederik ;
Pleimes, Dirk ;
Radue, Ernst-Wilhelm ;
Sandbrink, Rupert ;
Kappos, Ludwig ;
Pohl, Christoph .
JAMA NEUROLOGY, 2014, 71 (03) :306-314
[2]   Dimethyl Fumarate: A Review in Relapsing-Remitting MS [J].
Blair, Hannah A. .
DRUGS, 2019, 79 (18) :1965-1976
[3]   Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence [J].
Boltjes, Robin ;
Knippenberg, Stephanie ;
Gerlach, Oliver ;
Hupperts, Raymond ;
Damoiseaux, Jan .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (06) :715-725
[4]   Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis [J].
Brownlee, Wallace J. ;
Altmann, Dan R. ;
Prados, Ferran ;
Miszkiel, Katherine A. ;
Eshaghi, Arman ;
Wheeler-Kingshott, Claudia A. M. Gandini ;
Barkhof, Frederik ;
Ciccarelli, Olga .
BRAIN, 2019, 142 :2276-2287
[5]   Classifying multiple sclerosis patients on the basis of SDMT performance using machine learning [J].
Buyukturkoglu, Korhan ;
Zeng, Dana ;
Bharadwaj, Srinidhi ;
Tozlu, Ceren ;
Mormina, Enricomaria ;
Igwe, Kay C. ;
Lee, Seonjoo ;
Habeck, Christian ;
Brickman, Adam M. ;
Riley, Claire S. ;
De Jager, Philip L. ;
Sumowski, James F. ;
Leavitt, Victoria M. .
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (01) :107-116
[6]   Cortical lesion load associates with progression of disability in multiple sclerosis [J].
Calabrese, Massimiliano ;
Poretto, Valentina ;
Favaretto, Alice ;
Alessio, Sara ;
Bernardi, Valentina ;
Romualdi, Chiara ;
Rinaldi, Francesca ;
Perini, Paola ;
Gallo, Paolo .
BRAIN, 2012, 135 :2952-2961
[7]   Cortical lesions in multiple sclerosis [J].
Calabrese, Massimiliano ;
Filippi, Massimo ;
Gallo, Paolo .
NATURE REVIEWS NEUROLOGY, 2010, 6 (08) :438-444
[8]   Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high-dose pharmaceutical-grade biotin (MD1003) [J].
Collongues, Nicolas ;
Kuhle, Jens ;
Tsagkas, Charidimos ;
Lamy, Julien ;
Meyer, Nicolas ;
Barro, Christian ;
Parmar, Katrin ;
Amann, Michael ;
Wuerfel, Jens ;
Kappos, Ludwig ;
Moreau, Thibault ;
Seze, Jerome .
BRAIN AND BEHAVIOR, 2021, 11 (02)
[9]   Secondary Progressive Multiple Sclerosis New Insights [J].
Cree, Bruce A. C. ;
Arnold, Douglas L. ;
Chataway, Jeremy ;
Chitnis, Tanuja ;
Fox, Robert J. ;
Ramajo, Angela Pozo ;
Murphy, Niamh ;
Lassmann, Hans .
NEUROLOGY, 2021, 97 (08) :378-388
[10]   Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats [J].
Feige, Julia ;
Moser, Tobias ;
Bieler, Lara ;
Schwenker, Kerstin ;
Hauer, Larissa ;
Sellner, Johann .
NUTRIENTS, 2020, 12 (03)